REGENXBIO Inc (RGNX): Revenue Growth QoQ

Corporate company logo of regenxbio.com (RGNX)

The development of REGENXBIO Inc. (RGNX) relies on gene drug test results and external financing. Quarterly revenue growth rates visualize current income dynamics, where the -69.20 level captures the latest values. Despite global logistics risks and patent disputes, a strong reputation in bioengineering and partnerships with pharma behemoths strengthen the company's investment potential.

RGNX (REGENXBIO Corp) Quarterly Sales Growth history from 07/04/2022 to 11/20/2026

Analytical breakdowns for REGENXBIO (RGNX)

- stock price and consensus target price:
- stock exchange capitalization data:
- cash and cash flow metrics:
Comprehensive company analysis:RGNX - REGENXBIO
Mass-produced product of regenxbio.com

Fundamental asset selection requires analyzing revenue dynamics to identify market cycles. This metric measures the rate of revenue change between quarters, signaling a cooling of demand prior to the publication of official reports. For REGENXBIO Inc. (RGNX), this growth confirms the effectiveness of investments in an elite staff of geneticists and the R&D base. By analyzing the quarterly sales growth rate, an investor assesses the commercialization of the company's gene platforms.

Direct competitors

TEM - Revenue Growth QoQ|Quarterly Sales Growth Rate qiagen.com QGEN|IONS: Quarterly Revenue Growth|Repligen Corp - Quarterly Revenue Increase|RNA (Avidity Corp) - Quarterly Revenue Growth|CRISPR Therapeutics Corp - Revenue Dynamics QoQ|Revenue Growth QoQ genedx.com (WGS)|Quarterly Revenue Growth ultragenyx.com (RARE)|Quarterly Revenue Growth BEAM (Beam Therapeutics Inc)|Sarepta Therapeutics Inc (SRPT) - Quarterly Revenue Growth Rate|twistbioscience.com - Quarterly Revenue Growth|10x Genomics, Inc. - Sales Change QoQ|NTLA (Intellia Corp) - Quarterly Sales Growth|Quarterly Sales Growth stoketherapeutics.com|Quarterly Sales Growth BLFS|Quarterly Sales Growth Wave Life Sciences Corp (WVE)|Quarterly Revenue Growth MAZE|Quarterly Sales Growth Rate Sionna Therapeutics Inc|Revenue Growth QoQ Prime Medicine Corp PRME|tayshagtx.com (TSHA) - Quarterly Revenue Growth Rate|QURE - Revenue Growth QoQ|MeiraGTx Holdings (MGTX) - Quarterly Sales Growth|SLDB (Solid Corp) - Quarterly Sales Growth|Revenue Change vs Previous Quarter Ocugen Corp OCGN|PACB (Pacific Biosciences) - Quarterly Revenue Growth|Revenue Growth QoQ BNTC|Quarterly Revenue Growth DSGN|Quarterly Sales Growth Rocket Pharma RCKT|Quarterly Sales Growth Rate FDMT|Quarterly Revenue Growth Lexeo Therapeutics LXEO|KRRO - Revenue Growth QoQ|EDIT (Editas Medicine, Inc.) - Sales Growth QoQ|SLN: Quarterly Revenue Growth|ProQR - Quarterly Revenue Increase|CDXS (Codexis) - Quarterly Revenue Growth|Sangamo (SGMO) - Quarterly Sales Growth Rate|Quarterly Revenue Growth NAUT|Quarterly Sales Growth Metagenomi, Inc. MGX|Revenue Growth QoQ Precision BioSciences DTIL|Quarterly Revenue Increase GBIO|BOLD - Revenue Growth QoQ|Quarterly Sales Growth Rate Exicure Inc. XCUR|Imunon, Inc. (IMNN) - Revenue Growth QoQ|RXi Pharmaceuticals - Quarterly Revenue Increase|MBIO (Mustang Bio) - Quarterly Revenue Growth|Sales Growth QoQ RNAZ (transcodetherapeutics.com)|Revenue Growth QoQ Bionano (BNGO)|Applied DNA Sciences - Sales Growth QoQ|Quarterly Revenue Growth BLUE (bluebirdbio.com)|ImmunoPrecise Antibodies (IPA) - Quarterly Revenue Growth Rate|omegatherapeutics.com - Quarterly Revenue Growth|Revenue Change vs Previous Quarter Singular Genomics Systems Inc (OMIC)|RGLS: Quarterly Revenue Growth|Syros Pharmaceuticals, Inc (SYRS) - Quarterly Revenue Growth|TBIO (telesisbio.com) - Quarterly Revenue Growth|TCON: Quarterly Revenue Increase|Revenue Growth QoQ Unity Biotechnology, Inc (UBX)